Anyone can contribute to The Roar and have their work featured alongside some of Australia’s most prominent sports journalists. Queensland will hunt a vital Sheffield Shield win at the Gabba aft ...
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results